Literature DB >> 26973100

Differential effects of amyloid-beta 1-40 and 1-42 fibrils on 5-HT1A serotonin receptors in rat brain.

Mathieu Verdurand1, Fabien Chauveau2, Alexia Daoust2, Anne-Laure Morel2, Frédéric Bonnefoi3, François Liger3, Anne Bérod2, Luc Zimmer4.   

Abstract

Evidence accumulates suggesting a complex interplay between neurodegenerative processes and serotonergic neurotransmission. We have previously reported an overexpression of serotonin 5-HT1A receptors (5-HT(1A)R) after intrahippocampal injections of amyloid-beta 1-40 (Aβ40) fibrils in rats. This serotonergic reactivity paralleled results from clinical positron emission tomography studies with [(18)F]MPPF revealing an overexpression of 5-HT(1A)R in the hippocampus of patients with mild cognitive impairment. Because Aβ40 and Aβ42 isoforms are found in amyloid plaques, we tested in this study the hypothesis of a peptide- and region-specific 5-HT(1A)R reactivity by injecting them, separately, into the hippocampus or striatum of rats. [(18)F]MPPF in vitro autoradiography revealed that Aβ40 fibrils, but not Aβ42, were triggering an overexpression of 5-HT(1A)R in the hippocampus and striatum of rat brains after 7 days. Immunohistochemical approaches targeting neuronal precursor cells, mature neurons, and astrocytes showed that Aβ42 fibrils caused more pathophysiological damages than Aβ40 fibrils. The mechanisms of Aβ40 fibrils-induced 5-HT(1A)R expression remains unknown, but hypotheses including neurogenesis, glial expression, and axonal sprouting are discussed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-HT1A receptors; Alzheimer's disease; Amyloid-beta peptides; Positron emission tomography; Serotonin

Mesh:

Substances:

Year:  2015        PMID: 26973100     DOI: 10.1016/j.neurobiolaging.2015.12.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  5 in total

1.  Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats.

Authors:  Bae Kun Shin; Suna Kang; Da Sol Kim; Sunmin Park
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

Review 2.  Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.

Authors:  Boyi Zong; Fengzhi Yu; Xiaoyou Zhang; Wenrui Zhao; Peng Sun; Shichang Li; Lin Li
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

3.  Protective Effects of 5-HT1A Receptor Inhibition and 5-HT2A Receptor Stimulation Against Streptozotocin-Induced Apoptosis in the Hippocampus.

Authors:  Siamak Shahidi; Nasrin Hashemi-Firouzi; Simin Afshar; Sara Soleimani Asl; Alireza Komaki
Journal:  Malays J Med Sci       Date:  2019-04-30

4.  Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach.

Authors:  Hugo Geerts; Athan Spiros
Journal:  Alzheimers Dement       Date:  2020-04-07       Impact factor: 21.566

5.  Impact of amyloid-beta changes on cognitive outcomes in Alzheimer's disease: analysis of clinical trials using a quantitative systems pharmacology model.

Authors:  Hugo Geerts; Athan Spiros; Patrick Roberts
Journal:  Alzheimers Res Ther       Date:  2018-02-02       Impact factor: 6.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.